*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Thomas Turner
PhD Proposal Presentation
Date: May 5th
Time: 2-4 pm
Bluejeans Link: https://bluejeans.com/530197328
Thesis Advisor:
Edward A. Botchwey, PhD
Thesis Committee:
Andrés García, PhD
Valeria Milam, PhD
Andrew Neish, MD
Matthew Spite, PhD
Nick Willett, PhD
Title: Shifting the Balance of Inflammatory and Pro-Resolving Lipid Mediators in Volumetric Muscle Loss Injuries
Abstract:
Extremity trauma involving large tissue loss presents a significant clinical challenge for both general and military populations. In challenging cases resulting in volumetric muscle loss (VML), the current gold standard treatment is surgical reconstruction with muscle flap autografts or free tissue transfer. However, excessive fibrosis and fatty infiltration frequently impair regeneration and lead to significant long-term disabilities and chronic pain. The overarching hypothesis of the proposed research is that critical VML injuries have a dysregulated inflammatory lipid-mediator response, characterized by an abundance of pro-inflammatory mediators compared to pro-resolving mediators (SPMs), that impairs the regenerative capacity of muscle. Furthermore, the local delivery of SPMs in combination with the sequestration of pro-inflammatory lipid mediators will promote the timely resolution of inflammation and activate endogenous pathways of muscle regeneration. We have established a modular polyethylene glycol-maleimide (PEG-4MAL) biomaterial platform that can: 1) enable controlled release of aspirin-triggered resolvin D1 (AT-RvD1) or docosahexaenoic acid (DHA), an SPM precursor, to induce pro-resolving immune subsets, and 2) serve as a scaffold to sequester pro-inflammatory mediators using oligonucleotide aptamers. We will test whether sequestration of pro-inflammatory mediator LTB4 in aptamer functionalized PEG-4MAL hydrogels promotes inflammation resolution and enhances muscle regeneration following VML used alone or in combination with AT-RvD1 or DHA delivery.
